Alnylam Pharmaceuticals Inc 's Income per employee grew in the second quarter 2026 on a trailing twelve month basis to , the contribution of Alnylam Pharmaceuticals Inc 's employees, reached a new high of $ 323,195income per employee.
The Healthcare sector has seen employees of 37 other companies achieving higher income per employee. While Alnylam Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 322 to 542.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALNY Net Income per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Net Income Change	-	-	-	-	-
Net Income per Employee (TTM) $	323,195	228,506	138,810	30,737	-114,325
ALNY's Total Ranking	# 542	# 322	# 559	# 1614	# 2464
Seq. Net Income Change	-20.15 %	10.5 %	-25.75 %	-	-

ALNY Company Profile >> Back to ALNY Efficiency Comparisons >> Compare ALNY Net Income per Employee to its Competitors

ALNY Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 38
Healthcare Sector	# 63
Overall Market	# 542

Net Income per Employee Statistics
High	Average	Low
$ 323,195	$ -172,325	$ -472,849
(Jun 30 2026)		(Sep 30 2022)

Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector	Income per Employee	Income 12 month ending Jun 30 2026	Number of Employees Jun 30 2026
Glucotrack Inc	554,600.00	$ 8.319 Million	15
Eli Lilly And Company	534,224.00	$ 26,711.200 Million	50,000
Silexion Therapeutics Corp	489,714.29	$ 6.856 Million	14
Sanuwave Health Inc	477,290.91	$ 26.251 Million	55
Acadia Pharmaceuticals Inc	476,796.99	$ 380.484 Million	798
Biolife Solutions Inc	374,070.97	$ 57.981 Million	155
Indivior Pharmaceuticals Inc	356,000.00	$ 356.000 Million	1,000
Neurocrine Biosciences Inc	352,750.00	$ 705.500 Million	2,000
Jazz Pharmaceuticals Plc	325,523.53	$ 940.763 Million	2,890
Alnylam Pharmaceuticals Inc	323,195.20	$ 807.988 Million	2,500
Spero Therapeutics Inc	295,320.00	$ 7.383 Million	25
Eton Pharmaceuticals Inc	288,363.64	$ 12.688 Million	44
Bristol myers Squibb Company	285,353.85	$ 9,274.000 Million	32,500
Regeneron Pharmaceuticals Inc	280,902.01	$ 4,328.700 Million	15,410
Adma Biologics Inc	261,139.10	$ 168.957 Million	647
Siga Technologies Inc	247,213.16	$ 12.113 Million	49
Interpace Biosciences Inc	239,676.47	$ 24.447 Million	102
Lantheus Holdings Inc	230,766.97	$ 275.305 Million	1,193
Entrada Therapeutics Inc	222,888.16	$ 33.879 Million	152
Lensar Inc	219,520.00	$ 32.928 Million	150
Standard Biotools Inc	218,267.35	$ 84.906 Million	389
Meiragtx Holdings Plc	195,858.56	$ 78.931 Million	403
Black Hawk Acquisition Corporation	189,685.00	$ 0.379 Million	2
Intuitive Surgical Inc	185,529.64	$ 3,157.900 Million	17,021
Zoetis Inc	180,413.79	$ 2,616.000 Million	14,500
Arcutis Biotherapeutics Inc	176,146.89	$ 62.356 Million	354
Transmedics Group Inc	170,973.27	$ 153.534 Million	898

Date modified: 2026-09-14T03:47:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.